X0306 4 2022-03-01 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001239546 BOYER ANDREW S C/O AMNEAL PHARMACEUTICALS, INC. BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President Class A Common Stock 2022-03-01 4 M 0 12346 A 178836 D Class A Common Stock 2022-03-01 4 F 0 6192 4.45 D 172644 D Class A Common Stock 2022-03-01 4 M 0 31370 A 204014 D Class A Common Stock 2022-03-01 4 F 0 15733 4.45 D 188281 D Restricted Stock Units 2022-03-01 4 M 0 12346 0.00 D Class A Common Stock 12346 12346 D Restricted Stock Units 2022-03-01 4 M 0 31370 0.00 D Class A Common Stock 31370 94113 D Restricted Stock Units 2022-03-03 4 A 0 157005 0.00 A Class A Common Stock 157005 157005 D Performance-Based Restricted Stock Units 2022-03-03 4 A 0 314010 0.00 A Class A Common Stock 314010 314010 D Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. On March 1, 2019, the reporting person was granted 49,383 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. On March 1, 2021, the reporting person was granted 125,483 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units vest in four equal annual installments beginning on March 3, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents a performance-based restricted stock unit grant of 157,005 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period. /s/ Meredith Cook, Attorney-in-fact 2022-03-03